Company / Operating Cash Flow per Share
Amgen Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$18.55
FY2025
5-year range
$15.86 / $21.46
FY2021-FY2025
Trend
-13.6%
vs FY2024
Sector context
#6 of 210
Health Care
What the data says
Among 210 Health Care companies, Amgen is in the top 3% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $13.73 in FY2016 to $21.46 in FY2024.
Based on SEC 10-K filings.
18.55 in FY2025 with a 5-year CAGR of +0.9%. Top quartile in the Health Care sector.
Improved from $15.86 to $18.55 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +2.1%
- 5-Year CAGR
- +0.9%
- 10-Year CAGR
- -
Sector benchmark
+249.9% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 13.6% year-over-year.
- Ranks #6 out of 210 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.55 | -13.6% |
| FY2024 | $21.46 | +35.3% |
| FY2023 | $15.86 | -8.9% |
| FY2022 | $17.41 | +8.7% |
| FY2021 | $16.01 | -9.8% |
| FY2020 | $17.75 | +22.1% |
| FY2019 | $14.53 | -7.1% |
| FY2018 | $15.64 | +3.3% |
| FY2017 | $15.14 | +10.3% |
| FY2016 | $13.73 | +7.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026